Aristotle Atlantic Partners, LLC's Large Cap Growth Strategy outperformed the Russell 1000 Growth Index in Q2 2024. The investor letter highlighted DexCom, Inc. (NASDAQ:DXCM), a medical device company, with potential for investment growth.